Join the insightful webinar on the evolution of clinical technology, growing complexity of clinical research and uncover the current challenges and gaps in eClinical tech. Our esteemed speakers, including Medrio's CEO Nicole Latimer, will share their expertise and discuss the future of trials.
The Medrio and Pharmaseal partnership offers a validated data integration solution that simplifies study management. Learn how their integrated EDC and CTMS can eliminate data discrepancies and manual validation in this webinar.
In this webinar Nicole Latimer and Melissa Newara are joined by Dr. Frances Rubenstein from Nevro to discuss how Nevro, a medical device company, implemented ePRO to close gaps in data accuracy, reduce context switching for staff, and enhance patient convenience.
In this webinar, we will explore the powerful way that ePRO and eConsent tools, when implemented effectively, can enhance the participant experience and improve compliance while reducing the burden on site staff.
Many early phase studies rely on manual methods of managing participant randomization and the study supply chain. But increasing complexities in both study design and global supply chain necessitate more flexible, responsive solutions for early phase studies, in particular.
This webinar session focused on helping teams identify technology solutions that are efficient, cost-effective, and most importantly, right-sized to get your devices and diagnostics to-market before the competition.
This webinar session focused on how Medrio’s integrated RTSM solution can be optimized to reduce the noise of complicated clinical trials and leave you with clear, actionable data for better supply management.
Part 1 of our series looked at how eConsent strengthens your consent process to ensure better patient comprehension, adherence, and retention. Our experts Melissa and David are back to dig into ePRO and how you can set your study up to achieve as much as 97% compliance with patient reported outcomes.
It’s no secret that patient recruitment and retention is one of the most significant challenges in clinical studies. With 35% of patients who dropped out of trials citing the consent form as confusing, you have an opportunity to ensure that your study’s consent process is simplified and designed for patient comprehension.